PECAM1 and neoplasm: On the other hand, when the vascularization in these tumors was assessed, lucanthone treatment was found to significantly reduce CD31 positivity, an endothelial marker of blood vessels [46]both inside and at the border of the tumor (Fig. 7A-E), a finding consistent with our previous work [8].